Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Investing in stocks requires a strategic approach. Learn about the best strategies to enhance your success and navigate the stock market effectively.
22,240 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As volatility climbs in 2026, a tax-savvy move is drawing attention: converting traditional IRAs to Roth IRAs when va...
Amazon enters the back half of 2026 with sustained AWS growth, a scaling silicon stack, and a resilient Prime-driven ...
Is Nebius the nebius next amazon? This article digs into Nebius's model, how it stacks up to Amazon, and what it woul...
As Cricut reports its 2025 earnings, investors weigh growth engines, profitability, and strategic bets. This guide br...
As velocity financial readies its quarterly release, investors seek clues about growth, profitability, and risk. This...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
A prominent institutional investor revealed a sizable Callaway Golf stake as the stock surged. This article breaks do...
European banks are delivering surprising gains in 2026, challenging U.S. rivals. This guide breaks down why the trend...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
BYD launches a five-year plan to outrun rivals and become the world’s largest automaker, with Stella Li steering a gl...